Previous studies have shown that hepatocellular carcinoma (HCC) develops more frequently in hepatitis B virus surface antigen (HBsAg)-transgenic mice (Alb/HBs) than in wild-type (WT) mice. However, the mechanism of this HCC model has not been well documented. Toll-like receptor 4 (Tlr4) signaling probably links innate immunity and HCC progression. This study was designed to investigate the role of innate immunity in hepatocarcinogenesis in Alb/HBs mice. Immunohistochemical analysis of liver specimens from Alb/HBs mice (16 per group) showed that the oncogenes Bmi1 (16/16, 100%) and Dkk1 (13/16, 81.25%) were highly expressed in Alb/HBs mice, whereas the other oncogenes evaluated were expressed in smaller percentages of mice (Afp, 9/16, 56.2%; Ctnnb1, 5/16, 31.3%; Epcam, 0/16; 0%). Comparable results were obtained by quantitative PCR analysis. Hepatic gene expression of Tlr2, Tlr4, Il6 and Tnf was additionally elevated in Alb/HBs mice. Stimulation of primary murine hepatocytes with cell culture-derived HBV particles or LPS increased the expression of oncogenes (Bmi1, Dkk1) and inflammatory factors (Tnf, Il6, Tlr4). Proliferation and colony formation of hepatoma cells were enhanced by treatment with HBV and LPS and were impaired by the suppression of Bmi1 and Dkk1 by small interfering RNAs. Substantial induction of BMI1 and DKK1 was found in liver biopsy samples from patients with HBV-related HCC but not in HCC samples without HBV infection background. These findings suggest that innate immunity may link inflammation and tumor progression during chronic HBV infection, involving the oncogenes BMI1 and DKK1.
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world and is an important cause of cancer death. It is the fifth most common malignancy among men and the seventh most common malignancy among women. Approximately 696,000 patients die of HCC every year. Chronic hepatitis B virus (HBV) infection is a key risk factor for chronic hepatitis, liver cirrhosis, and HCC.
1,2 HBV infection increases the risk of liver cancer by approximately 15 to 20 times and accounts for approximately 78% of all cases of HCC worldwide. 3 Despite efficient suppression of HBV as a result of long-term nucleos(t)ide analogue therapy, hepatocarcinogenesis still occurs, especially among patients with high levels of HBV surface antigen (HBsAg). 4, 5 Furthermore, patients with residual HBsAg titers higher than 1,000 IU/mL are at increased risk of HCC. 6 In addition, the typical histological finding of "ground glass" hepatocytes, indicating the accumulation of HBV surface proteins, first demonstrated the direct oncogenic potential of HBsAg. 7, 8 It has been reported that HCC develops more frequently among HBsAg transgenic mice than among wild-type (WT) mice. 8 Therefore, the mechanism by which HBsAg leads to the transformation from normal liver cells to HCC has attracted widespread interest.
Recent studies have demonstrated that genetic alterations alone cannot account for the complexity of human HBVrelated hepatocarcinogenesis; DNA methylation, histone modifications, and innate immunity are also involved in this process. [9] [10] [11] The innate immune system is believed to play an important role in maintaining homeostasis in the liver. Accumulating evidence has demonstrated that the innate immune system plays an important role in a variety of liver diseases, including HCC. 12 Toll-like receptors (TLRs) are a family of pattern-recognition receptors that play a crucial role in the activation of the innate immune system by recognizing pathogen-associated molecular patterns. 13 TLRs are expressed on hepatocytes, hepatic stellate cells, endothelial cells, and Kupffer cells in the liver. To date, >10 members of the TLR family have been identified in humans.
14 Approximately 80% of cases of HCC are preceded by chronic liver inflammation, fibrosis, and cirrhosis. 15 During HCC progression, the liver may be exposed to various TLR ligands via the portal vein, and this exposure can lead to consistent activation of innate immunity that may facilitate the development of HCC.
16
TLR4 is one of the most intensively studied members of the TLR family. 17 Under normal circumstances, the expression of TLR4 is at a relatively low level; however, when the liver is damaged under proinflammatory conditions, TLR4 expression is up-regulated. 18 To date, experimental studies have shown that TLR4 may play an important role in HCC carcinogenesis, metastasis, and progression. 19, 20 We speculated that TLR4 plays a crucial role in HCC progression because of activated innate immunity. To test this theory and to determine its role in the development of HBV-related HCC, we examined the expression of the HCC marker Afp, the stem cell marker Epcam, and the HCC oncogenes Bmi1, Dkk1, and Ctnnb1 in HBsAgtransgenic (Alb/HBs) mice. To link liver inflammation and HCC progression, we investigated Tlr4 activation and HBV stimulation of primary murine hepatocytes (PMHs).
Material and Methods

Animals
Transgenic mice expressing HBsAg (Tg[Alb-lHBV]Bri44; Alb/HBs) overexpress all HBV envelope proteins, as described elsewhere. 7, 8 Alb/HBs mice and their wild-type (WT) littermates were bred at the University Hospital of Essen, fed ad libitum, and given humane care according to the criteria outlined in the guide for the care and use of laboratory animals, prepared by the Society for Laboratory Animal Science (GV-SOLAS).
Immunohistochemical analysis
Liver specimens from Alb/HBs mice and WT mice were fixed in formalin and embedded in paraffin. Sections of paraffinembedded tissue were routinely stained with hematoxylin and eosin. In addition, HBsAg, Afp, Bmi1, Epcam, Ctnnb1, and Dkk1 were visualized by immunohistochemical analysis. The staining was performed as previously described. 21 Details regarding primary antibodies are provided in Supporting Information Table 1 . The pictures were taken with an EVOS XL core microscope (Advanced Microscopy Group, Thermo Fischer Scientific, Mill Creek, WA).
Quantitative polymerase chain reaction assay
Liver specimens were obtained from Alb/HBs mice and WT mice. Total RNA was extracted with the Qiazol reagent and the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. Analysis with qRT-PCR was performed with the QuantiFast SYBR Green RT-PCR Kit (Qiagen) using 0.1 to 0.3 mg of total RNA (manufacturer's protocol). The primer sets used for PCR amplification are shown in Supporting Information Table 2 . Changes in gene expression were determined by the delta delta cycle threshold method (DDCt), with the housekeeping gene b-actin (Actb) as a control.
Cell culture
Murine hepatoma cell lines Hepa1-6 were obtained from the American Type Culture Collection Cell Bank, were grown in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum, 1% L-glutamine, 100 U/mL penicillin, and 100 lg/mL streptomycin. The cells were maintained at 378C in a 5% CO 2 humidified atmosphere.
HBV preparation and stimulation
The HBV-transduced cell line HepG2.117 was cultured as described elsewhere. 22 HBV-containing supernatants were collected. Virions were precipitated overnight with 6% polyethylene glycol 8000 (Sigma, Darmstadt, Germany) at 48C, concentrated by centrifugation (12,000g for 60 min at 48C), and stored at 2808C. A nonparticle control was produced by precipitating supernatants of naive hepatoma cells. PMHs were seeded in 24-well plates and incubated with HBV particles obtained from HepG2.117 (MOI >1,000) with a PMH maintenance medium (Williams medium, 10% FBS, 2% DMSO, 1% L-glutamine, insulin [5 mg/mL], 1% HEPES, 2% nonessential amino acid, hydrocortisone hemisuccinate [2.5 mg/mL], and epidermal growth factor [55 ng/mL]), including 4% PEG8000 for 24 h. At the end of incubation, cells were washed three times with PBS and were further cultured in PMH maintenance medium; the medium was changed every second day.
What's new? Chronic hepatitis B virus (HBV) infection is a key risk factor for hepatocellular carcinoma (HCC). TLRs are pattern-recognition receptors that play a crucial role in innate immune system activation. This study found that Tlr4 and oncogenes Bmi1 and Dkk1 were significantly induced in HBV surface antigen (HBsAg)-transgenic mice. Stimulation with HBV or lipopolysaccharides increased expression of Bmi1 and Dkk1 in primary hepatocytes and hepatoma cells and enhanced proliferation and colony formation in hepatoma cells. This suggests that TLR signaling links inflammation and tumor progression during chronic HBV infection and promotes the progression of HBV-related HCC through BMI1 and DKK1.
Isolation and culture of murine hepatocytes
PMHs were prepared from Alb/HBs mice and WT mice by liberase perfusion, as described previously. 23 PMHs had been separated from non-parenchymal liver cells by low-speed centrifugation (50g for 10 min at 48C). PMHs were seeded into collagen I-coated culture plates for 24 h and stimulated with LPS (10 mg/mL), cell culture-derived HBV (multiplicity of infection [MOI] >1,000), or a nonparticle control for additional 24 to 96 h, followed by RNA isolation and qRT-PCR analysis.
Cell proliferation assay
Hepa1-6 cells (5 3 10 3 cells per well) were cultured in 96-well tissue culture plates until they reached 50% confluence. Cells were stimulated with LPS (10 mg/mL) or cell-culture derived HBV (MOI >1,000) for 3 days. The proliferation ability was determined by CCK-8 assays (Dojindo Molecular Technologies, Gaithersburg, MA) after 24 h, 48 h, or 72 h. Briefly, 10 lL of water-soluble formazan dye was added to each well and incubated for 2 h. The absorbance at 450 nm was measured with a FLUOstar Omega reader (BMG LABTECH, Ortenberg, Germany). The absorbance of the negative control (optical density, OD) was considered to be 0.
Colony formation assay
A total of 200 Hepa1-6 cells were seeded into a six-well plate and stimulated with LPS (10 mg/mL) or cell culture-derived HBV (MOI >1,000) for 7 days. The cells were then rinsed with PBS twice, fixed with 10% formaldehyde, and stained with 0.1% crystal violet in 10% ethanol. Microscopic colonies composed of >50 cells were counted in each well.
Transfection
We obtained siRNAs from Qiagen and transfected them into Hepa1-6 cells at indicated concentrations with Lipofectamine RNAiMAX reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Details regarding Bmi1 siRNA and Dkk1 siRNA are provided in Supporting Information Table 3 . Knockdown of Bmi1 and Dkk1 gene expression was confirmed with quantitative RT-PCR.
Patients and tissue specimens
Samples of tumor tissues were randomly obtained from HCC patients who underwent resection at the Department of Pancreato-Biliary Surgery, Sun Yat-sen Memorial Hospital (Guangzhou, China). None of the patients had undergone chemotherapy or radiation therapy before radical resection of the tumor. BMI1, DKK1, and HBsAg expression in these tumor tissues were investigated with quantitative PCR analysis. BMI1 and DKK1 were immunohistochemically stained in parafin-embedded tissues. The project was approved by the ethics committee of Sun Yat-sen Memorial Hospital. Written informed consent was obtained from either the patient or the patient's guardian.
Statistical analysis
Statistical analysis was performed with the SPSS software package (version 13.0, SPSS, Chicago, IL). Representative data from series of at least three independent experiments carried out in triplicate are presented as mean 6 standard error of the mean (SEM) unless otherwise indicated. Student's t-test was used to indicate differences and p values <0.05 were considered to be statistically significant.
Results
Hepatic (Figs. 3b and 3d ). The magnitude of fold induction of Bmi1 and Dkk1 was higher in PMHs from Alb/HBs mice than in PMHs from WT mice (Figs. 1fj) . Interestingly, the data showed that HBV and LPS also enhanced the expression of Tlr4 in PMH obtained from Alb/HBs or wild-type mice (Figs. 3e and 3f) . However, significant induction of Tnf and Il6 could only be observed in HBV-and LPS-treated Alb/HBs-derived PMHs (Figs. 3gj) . These findings suggest that PMH isolated from Alb/ HBs mice exhibit a higher sensitivity to innate immune stimulation. The Ctnnb1 expression was significantly induced only after 48 h of stimulation in Alb/HBs-derived PMHs, whereas treatment with HBV and LPS did not affect the expression of Epcam in any PMH preparations (Supporting Information Fig.  1 ). These findings indicate that Bmi1 and Dkk1 expression in PMHs can be directly induced by HBV or LPS exposure in vitro.
Treatment with HBV and LPS enhanced proliferation and cell colony formation in murine hepatoma cell line Hepa1-6 in vitro
Because PMHs show no proliferation under standard conditions in vitro, we used the murine hepatoma cell line Hepa1-6 to investigate the effect of HBV particles and lipopolysaccharide (LPS) on cell proliferation and colony formation. We first investigated the effect of HBV and LPS on the expression of Bmi1 and Dkk1 in Hepa1-6 cells. Quantitative PCR analysis showed that stimulation with HBV and LPS up-regulated the expression of Bmi1 and Dkk1 in Hepa1-6 cells in vitro (Figs. 4a and 4b) . Furthermore, CCK-8 cell proliferation analysis showed that Hepa1-6 cells treated with HBV exhibited significantly higher proliferation than did untreated control Hepa1-6 cells (Fig. 4c) . In addition, these HBV-treated Hepa1-6 cells also exhibited a significant increase in cell colony formation (Figs. 4d and 4e) . Similar results were observed in the LPS-treated group (Figs.  1fh) . Taken together, these findings show that treatment with HBV and LPS mediates enhanced proliferation and colony formation of Hepa1-6 cells.
Down-regulation of Bmi1 and Dkk1 in Hepa1-6 cells decreases proliferation and cell colony formation in vitro
To investigate the effects of Bmi1 and Dkk1 on Hepa1-6 cells, we used RNA interference (RNAi) to reduce Bmi1 or Dkk1 expression in Hepa1-6 cells. As shown in Figure 5 , quantitative PCR analysis revealed a significant knockdown of Bmi1 and Dkk1 in Hepa1-6 cells treated with Bmi1 short interfering RNA (siRNA) and Dkk1 siRNA, as compared to untreated control cells (Figs. 5a and b) . We further investigated whether the decrease in the expression of Bmi1 or Dkk1 affected the biological activities of Hepa1-6 cells. CCK-8 assays showed that the decrease in the expression of Bmi1 or Dkk1 that was caused by siRNA treatment significantly inhibited the proliferation of Hepa1-6 cells (Figs. 5c and 5d ). The colony formation assay found fewer colonies in the Hepa1-6 cells treated with Bmi1 siRNA and Dkk1 siRNA than in the untreated control cells (Figs. 5eh) . These findings indicate that the suppression of Bmi1 or Dkk1 not only inhibited the proliferation but also decreased the colony formation of Hepa1-6 cells.
The expression of BMI1 is elevated in human HBV-related HCC tissues
We used quantitative PCR analysis to investigate the expression of BMI1 and DKK1 in tissue specimens from 56 patients with HCC. As shown in Figure 6a BM1I expression was significantly higher in tissue specimens from HCC patients infected with HBV than in tissue specimens from HCC patients not infected with HBV (P < 0.01). The expression of DKK1 was also higher in HBV-infected HCC tissue specimens than in HCC tissue specimens not infected with HBV (p 5 0.047) (Fig. 6b) . Moreover, the expression of HBsAg was positively correlated with the expression of BMI1 in HBV-infected HCC tissues (Fig. 6c) 
Discussion
Hepatocarcinogenesis is a multifactorial disease in which the expression of a large number of genes, proteins, and other molecules from diverse cellular processes is altered. 24 HBV infection is an important risk factor for the development of HCC; both the HBx protein and the HBs protein are called viral oncoproteins. The HBx protein has been studied extensively. 25, 26 The HBs proteins are recognized as precursor lesions of HCC and are a risk factor for the postoperative recurrence of HCC. 27, 28 It has been estimated that more than half of HCC cases are related to HBV, and patients carrying HBsAg are at higher risk of HCC development than are uninfected persons. 29 Accumulating evidence suggests that innate immunity plays a crucial role in the progression of HBV-related HCC. TLRs are a family of transmembrane signalling receptors that are expressed on immune cells and liver cells. 30 We previously reported that activation of TLR3 and TLR4 can suppress HBV infection in vitro. 31 Recently, it has been suggested that TLR4 may affect HCC development. LPS, an agonist of TLR4, induces the interaction of TLR4 with the adaptor molecule MyD88, which in turn activates downstream NFjB signaling pathways, subsequently causing the production of inflammatory mediators and the promotion of HCC cell survival and proliferation. 32 It has been reported that HCC develops more frequently in Alb/HBs mice than in WT mice. 8 However, the mechanism of this HCC model has not been well documented. In the present study, quantitative real-time PCR (qRT-PCR) analysis showed that the expression of Tlr2 and Tlr4 as well as inflammatory cytokines Tnf Figure 2 . The expression of Bmi1, Dkk1, Ctnnb1, Afp, Tnf, Il6 and Tlr4 is up-regulated in the liver tissues and PMH prepared from Alb/HBs mice as compared to wild-type controls. Liver tissues from 12-month-old Alb/HBs (HBsAg-transgenic) mice (n 5 16) and wild-type (WT) littermates (n 5 3) were prepared, and total RNA was extracted. The expression of Bmi1, Dkk1, Ctnnb1, Afp, Epcam, Tnf, Il6, Tlr2 and Tlr4 mRNA was determined by quantitative polymerase chain reaction (PCR) analysis (a). Basal mRNA expression of these genes was compared in PMH isolated from 4-to 6-month-old Alb/HBs and wild-type mice (b). Changes in gene expression were determined by the delta delta cycle threshold (DDCt) method, referring to the housekeeping gene Actb. *p < 0.05. HBsAg, HBV surface antigen. and Il6 was upregulated in liver tissues from Alb/HBs mice as compared to liver tissues from WT mice. These findings led to suggest that consistent activation of hepatic innate immune system accompanies HCC progression in the Alb/ HBs mouse strain.
It has been reported that complex genetic and epigenetic alterations, chromosomal aberrations, mutations, and altered molecular pathways lead to the development of HCC. 33 HBV DNA sequences are frequently found to be integrated into the host genes encoding for proteins related to the control of Figure 4 . Treatment with HBV and LPS increased the expression of Bmi1 and Dkk1 and also enhanced cell proliferation and colony formation in Hepa1-6 cells in vitro. Hepa1-6 cells were stimulated with lipopolysaccharide (LPS, 10 mg/mL), cell culture-derived HBV particles (multiplicity of infection [MOI] >1,000), or a non-particle control. The expression of Bmi1 and Dkk1 was confirmed by quantitative polymerase chain reaction (PCR) analysis in Hepa1-6 cells (a, b). Changes in gene expression were determined by the delta delta cycle threshold (DDCt) method, referring to the housekeeping gene actin as a control. Cell proliferation was analyzed with CCK-8 assays (c, f). Cell colony formation was determined by a colony formation assay (d, g). The number of colonies was counted (e, h). *p < 0.05, **p < 0.01. OD, optical density. cell signaling, cellular proliferation, and viability. This integration leads to a cascade of interactive events that ultimately transform normal hepatocytes into malignant cells. 34 We previously reported that the oncogene Bmi1 plays an important role in HCC. 21, 35 Recently, it has been shown that DKK1 and CTNNB1 play a pivotal role in the initial phase of HCC progression. 36, 37 However, whether these genes participate in the progression of HBV-related HCC is still unclear. In the present study, immunohistochemical analysis and quantitative PCR showed that Bmi1, Dkk1, and Afp are highly upregulated in liver tissue from Alb/HBs mice as compared to WT mice, whereas Ctnnb1 was weakly expressed and Epcam was not expressed in liver tissue from Alb/HBs mice. These findings indicate that especially Bmi1 and Dkk1 may participate in the progression of HBV-related HCC.
To determine whether HBV directly affects HCC carcinogenesis, we isolated PMHs from Alb/HBs and WT mice. Treatment with HBV and LPS was used to stimulate the PMHs and Hepa1-6 cells. We found that treating PMHs and Hepa1-6 cells with HBV and LPS led to increased expression of the oncogenes Bmi1 and Dkk1 and to enhanced proliferation and colony formation of Hepa1-6 cells. Most importantly, the induction of Bmi1 and Dkk1 gene expression was higher in PMHs from Alb/HBs mice than in PMHs from WT mice. It has been reported that BMI1 plays a crucial role in the regulation of cell proliferation, stem cell maintenance, tumorigenesis, and tumor progression, including HCC. 38, 39 We previously demonstrated that overexpression of BMI1 enhances the proliferation, invasion, and tumor formation of human HCC cells. 35 Most importantly, we reported that forced expression of Bmi1 promotes malignant transformation of rat hepatic progenitor cells. 21 DKK1 is a secreted protein that has been clearly identified as a key regulator of Wnt/b-catenin signaling. Increased expression of DKK1 has been found in several human tumors. 40 However, the role of Bmi1 and Dkk1 in the progression of murine HCC is still unclear. In the present study, we found that Bmi1 siRNA and Dkk1 siRNA impair the proliferation and colony formation of Hepa1-6 cells in vitro. These findings indicate that Bmi1 and Dkk1 play a vital role in the proliferation and cell colony formation of Hepa1-6 cells. However, the mechanisms by which HBV and LPS induce Bmi1 and Dkk1 expression must be further investigated.
We investigated the expression of BMI1 and DKK1 in human HCC tissues. We previously demonstrated that BMI1 is up-regulated in human HCC tissues. 35 Accumulating evidence suggests that DKK1 plays an essential role in human HCC, 36, 40 but whether BMI1 and DKK1 participate in the progression of HBV-related HCC is still unclear. In the present study, quantitative PCR analysis and immunohistochemical staining showed that BMI1 and DKK1 expression is significantly increased in HCC tissues from HBV-infected patients as compared to HCC tissues from patients not infected with HBV. Most importantly, the expression of HBsAg is positively correlated with the expression of BMI1 mRNA in HBV-related HCC tissues. These findings indicate that BMI1 and DKK1 may play an important role in the progression of HBV-related HCC. Taken together, these findings suggest that TLR signaling links inflammation and tumor progression during chronic HBV infection and promotes the progression of HBV-related HCC through BMI1 and DKK1.
